McKesson Corporation (MCK) - Net Assets
Based on the latest financial reports, McKesson Corporation (MCK) has net assets worth $-3.86 Billion USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($88.33 Billion) and total liabilities ($92.19 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check MCK PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-3.86 Billion |
| % of Total Assets | -4.37% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -106.62% |
| Growth Volatility | 51.38 |
McKesson Corporation - Net Assets Trend (1995–2026)
This chart illustrates how McKesson Corporation's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see market cap of McKesson Corporation.
Annual Net Assets for McKesson Corporation (1995–2026)
The table below shows the annual net assets of McKesson Corporation from 1995 to 2026. Also explore MCK net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | $-834.00 Million | +50.77% |
| 2025-03-31 | $-1.69 Billion | -5.94% |
| 2024-03-31 | $-1.60 Billion | -7.32% |
| 2023-03-31 | $-1.49 Billion | +16.85% |
| 2022-03-31 | $-1.79 Billion | -223.93% |
| 2021-03-31 | $1.45 Billion | -78.45% |
| 2020-03-31 | $6.71 Billion | -30.67% |
| 2019-03-31 | $9.68 Billion | -15.94% |
| 2018-03-31 | $11.52 Billion | -8.60% |
| 2017-03-31 | $12.60 Billion | +20.99% |
| 2016-03-31 | $10.41 Billion | +9.96% |
| 2015-03-31 | $9.47 Billion | -8.21% |
| 2014-03-31 | $10.32 Billion | +45.94% |
| 2013-03-31 | $7.07 Billion | +3.50% |
| 2012-03-31 | $6.83 Billion | -5.39% |
| 2011-03-31 | $7.22 Billion | -4.14% |
| 2010-03-31 | $7.53 Billion | +21.62% |
| 2009-03-31 | $6.19 Billion | +1.18% |
| 2008-03-31 | $6.12 Billion | -2.42% |
| 2007-03-31 | $6.27 Billion | +6.20% |
| 2006-03-31 | $5.91 Billion | +11.98% |
| 2005-03-31 | $5.28 Billion | +2.13% |
| 2004-03-31 | $5.17 Billion | +9.32% |
| 2003-03-31 | $4.72 Billion | +14.23% |
| 2002-03-31 | $4.14 Billion | +12.13% |
| 2001-03-31 | $3.69 Billion | -1.94% |
| 2000-03-31 | $3.76 Billion | +22.23% |
| 1999-03-31 | $3.08 Billion | +92.07% |
| 1998-03-31 | $1.60 Billion | +10.07% |
| 1997-03-31 | $1.46 Billion | +29.76% |
| 1996-03-31 | $1.12 Billion | +4.51% |
| 1995-03-31 | $1.07 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to McKesson Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2444.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $22.29 Billion | % |
| Common Stock | $3.00 Million | % |
| Other Comprehensive Income | $-1.45 Billion | % |
| Total Equity | $-2.17 Billion | 100.00% |
McKesson Corporation Competitors by Market Cap
The table below lists competitors of McKesson Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
UBS Group AG
SW:UBSG
|
$101.41 Billion |
|
Agnico Eagle Mines Limited
TO:AEM
|
$102.19 Billion |
|
Cambricon Technologies Corp Ltd
SHG:688256
|
$102.34 Billion |
|
Pinduoduo Inc
F:9PDA
|
$102.48 Billion |
|
GSK PLC SP. ADR/2 NEW
F:GS70
|
$101.34 Billion |
|
China Yangtze Power Co Ltd
SHG:600900
|
$101.22 Billion |
|
Air Liquide SA
PA:AI
|
$101.06 Billion |
|
CVS Health Corp
NYSE:CVS
|
$101.04 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in McKesson Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from -1,694,000,000 to -2,172,000,000, a change of -478,000,000.
- Net income of 4,762,000,000 contributed positively to equity growth.
- Dividend payments of 381,000,000 reduced retained earnings.
- Share repurchases of 4,750,000,000 reduced equity.
- New share issuances of 89,000,000 increased equity.
- Other comprehensive income decreased equity by 521,000,000.
- Other factors increased equity by 323,000,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $4.76 Billion | +219.24% |
| Dividends Paid | $381.00 Million | -17.54% |
| Share Repurchases | $4.75 Billion | -218.69% |
| Share Issuances | $89.00 Million | +4.1% |
| Other Comprehensive Income | $-521.00 Million | -23.99% |
| Other Changes | $323.00 Million | +14.87% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares McKesson Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1995-03-31 | $11.76 | $874.65 | x |
| 1996-03-31 | $12.01 | $874.65 | x |
| 1997-03-31 | $17.25 | $874.65 | x |
| 1998-03-31 | $16.76 | $874.65 | x |
| 1999-03-31 | $11.18 | $874.65 | x |
| 2000-03-31 | $13.24 | $874.65 | x |
| 2001-03-31 | $13.03 | $874.65 | x |
| 2002-03-31 | $13.88 | $874.65 | x |
| 2003-03-31 | $15.81 | $874.65 | x |
| 2004-03-31 | $17.28 | $874.65 | x |
| 2005-03-31 | $17.94 | $874.65 | x |
| 2006-03-31 | $18.69 | $874.65 | x |
| 2007-03-31 | $20.57 | $874.65 | x |
| 2008-03-31 | $20.54 | $874.65 | x |
| 2009-03-31 | $22.20 | $874.65 | x |
| 2010-03-31 | $27.59 | $874.65 | x |
| 2011-03-31 | $27.45 | $874.65 | x |
| 2012-03-31 | $27.22 | $874.65 | x |
| 2013-03-31 | $29.58 | $874.65 | x |
| 2014-03-31 | $44.28 | $874.65 | x |
| 2015-03-31 | $40.30 | $874.65 | x |
| 2016-03-31 | $44.70 | $874.65 | x |
| 2017-03-31 | $56.50 | $874.65 | x |
| 2018-03-31 | $55.10 | $874.65 | x |
| 2019-03-31 | $49.06 | $874.65 | x |
| 2020-03-31 | $36.87 | $874.65 | x |
| 2021-03-31 | $9.00 | $874.65 | x |
| 2022-03-31 | $-11.63 | $874.65 | x |
| 2023-03-31 | $-10.48 | $874.65 | x |
| 2024-03-31 | $-11.92 | $874.65 | x |
| 2025-03-31 | $-13.22 | $874.65 | x |
| 2026-03-31 | $-17.50 | $874.65 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently McKesson Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.18%
- • Asset Turnover: 4.90x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (1.28%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1995 | 37.68% | 3.07% | 3.79x | 3.24x | $297.16 Million |
| 1996 | 12.07% | 0.99% | 3.91x | 3.12x | $23.22 Million |
| 1997 | 9.20% | 1.04% | 2.49x | 3.55x | $-11.66 Million |
| 1998 | 9.67% | 0.74% | 3.72x | 3.50x | $-5.32 Million |
| 1999 | 2.76% | 0.28% | 3.35x | 2.95x | $-222.84 Million |
| 2000 | 19.24% | 1.97% | 3.54x | 2.76x | $347.54 Million |
| 2001 | -1.31% | -0.11% | 3.64x | 3.13x | $-417.18 Million |
| 2002 | 10.12% | 0.84% | 3.75x | 3.22x | $4.98 Million |
| 2003 | 11.75% | 0.97% | 3.98x | 3.04x | $82.92 Million |
| 2004 | 12.52% | 0.93% | 4.28x | 3.14x | $129.97 Million |
| 2005 | -2.98% | -0.19% | 4.29x | 3.56x | $-684.51 Million |
| 2006 | 12.49% | 0.84% | 4.20x | 3.55x | $147.30 Million |
| 2007 | 15.35% | 1.04% | 3.88x | 3.82x | $335.70 Million |
| 2008 | 16.17% | 0.97% | 4.13x | 4.02x | $377.90 Million |
| 2009 | 13.29% | 0.77% | 4.22x | 4.08x | $203.70 Million |
| 2010 | 16.77% | 1.16% | 3.86x | 3.74x | $509.80 Million |
| 2011 | 15.65% | 1.01% | 3.63x | 4.28x | $408.00 Million |
| 2012 | 20.54% | 1.14% | 3.71x | 4.84x | $719.90 Million |
| 2013 | 18.93% | 1.09% | 3.52x | 4.92x | $631.00 Million |
| 2014 | 12.24% | 0.92% | 2.66x | 5.02x | $231.20 Million |
| 2015 | 15.58% | 0.82% | 3.32x | 5.69x | $528.90 Million |
| 2016 | 21.68% | 1.18% | 3.37x | 5.43x | $1.22 Billion |
| 2017 | 41.13% | 2.61% | 3.26x | 4.84x | $3.92 Billion |
| 2018 | 0.58% | 0.03% | 3.45x | 5.24x | $-1.08 Billion |
| 2019 | 0.35% | 0.02% | 3.59x | 6.16x | $-934.00 Million |
| 2020 | 13.41% | 0.39% | 3.77x | 9.13x | $228.90 Million |
| 2021 | -313.90% | -1.91% | 3.66x | 44.96x | $-4.68 Billion |
| 2022 | 0.00% | 0.42% | 4.17x | 0.00x | $1.29 Billion |
| 2023 | 0.00% | 1.29% | 4.44x | 0.00x | $3.71 Billion |
| 2024 | 0.00% | 0.97% | 4.58x | 0.00x | $3.16 Billion |
| 2025 | 0.00% | 0.92% | 4.78x | 0.00x | $3.46 Billion |
| 2026 | 0.00% | 1.18% | 4.90x | 0.00x | $4.98 Billion |
Industry Comparison
This section compares McKesson Corporation's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $332,468,920
- Average return on equity (ROE) among peers: 10.13%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| McKesson Corporation (MCK) | $-3.86 Billion | 37.68% | N/A | $101.38 Billion |
| Accendra Health Inc (ACH) | $924.17 Million | -4.47% | 4.51x | $68.03 Million |
| Akso Health Group ADR (AHG) | $8.84 Million | -15.38% | 1.31x | $807.33 Million |
| Cardinal Health Inc (CAH) | $548.20 Million | 15.51% | 2.36x | $43.01 Billion |
| Cencora Inc. (COR) | $-36.80 Million | 0.00% | 0.00x | $50.53 Billion |
| Cosmos Health Inc. (COSM) | $-17.48K | 0.00% | 0.00x | $16.63 Million |
| EDAP TMS SA (EDAP) | $27.36 Million | 5.53% | 0.94x | $154.80 Million |
| Empro Group Inc. Ordinary shares (EMPG) | $1.41 Million | 82.70% | 1.73x | $143.05 Million |
| EDAP TMS S.A. (FOCL) | $26.04 Million | 16.32% | 0.89x | $155.74 Million |
| Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) | $9.58 Million | -11.85% | 0.34x | $4.79 Million |
| Henry Schein Inc (HSIC) | $1.82 Billion | 12.94% | 0.82x | $7.86 Billion |
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; d… Read more